ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Epogee, the developer of a fat replacement, has raised $8.3 million in its first round of venture funding. The Indianapolis-based firm splits rapeseed oil into glycerin and fatty acids. It then revamps the molecule by inserting what it calls a propoxyl link between the glycerol backbone and the fatty-acid chains. Epogee claims the new structure prevents digestive enzymes from acting on the molecule, reducing calories absorbed from fat by 92%. The company will use the funds to expand manufacturing and technical support to customers.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X